Adjuvant abemaciclib combined with endocrine therapy (ET) has demonstrated a statistically significant and clinically ...

A 6-month fully remote weight-loss program tailored to veterans with serious mental illness yielded numerically greater ...

Kyverna Therapeutics stock upgraded to Strong Buy after positive phase 2 results for miv-cel in SPS and MG. Read the latest ...

The study suggests that adding a Bruton tyrosine kinase inhibitor (BTKi) to frontline chemoimmunotherapy in Richter ...

Objective sleepiness without daytime symptoms may indicate a more efficient sleep regulatory system, reducing hypertension risk. New research reveals that quick sleep onset may lower hypertension risk ...

Rezolute, Inc. is downgraded to a Sell after its phase 3 sunRIZE trial for congenital hyperinsulinism failed. Learn more ...

In statistics, data collection is a difficult process that demands thoughtful consideration. Securing a sufficient sample ...

The use of hormone replacement therapy (HRT) does not have an adverse effect on breast cancer risk according to results from ...

Cancer patients and survivors are more likely to report housing and utility insecurity than those who do not have a history of cancer, according research ...

Background Global warming poses a significant threat to human mental health, with disproportionate effects on vulnerable and ...

Early termination of the 6-minute walk test may be a practical and prognostic marker for severe adverse events in patients with COPD.